Opposing immune and genetic mechanisms shape oncogenic programs in synovial sarcoma

© 2021, The Author(s), under exclusive licence to Springer Nature America, Inc. Synovial sarcoma (SyS) is an aggressive neoplasm driven by the SS18–SSX fusion, and is characterized by low T cell infiltration. Here, we studied the cancer–immune interplay in SyS using an integrative approach that comb...

Full description

Bibliographic Details
Main Author: Regev, Aviv
Other Authors: Howard Hughes Medical Institute
Format: Article
Language:English
Published: Springer Science and Business Media LLC 2022
Online Access:https://hdl.handle.net/1721.1/134031.2